Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404923-130428609	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.6"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 14.5;Endometrial stromal cells: 30.9;Glandular and luminal cells: 37.7;Skeletal myocytes: 26.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;HeLa: 1.3;HMC-1: 4.4;NTERA-2: 2.2;U-2 OS: 9.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066349	Approved				"Secreted to extracellular matrix"	NA	NA		3600000		"Cluster 19: Lung - Lung function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA066349: AB_2685662"	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	1.8	0.1	1.5	10.1	2.7	0.0	0.7	0.0	3.7	2.0	0.0	7.0	1.1	3.0	1.0	3.0	2.1	1.6	2.3	3.5	0.0	0.5	0.0	27.6	0.1	0.7	0.1	0.4	0.7	0.0	0.2	2.6	0.2	2.7	0.5	0.0	0.5	4.9	0.5	0.3	2.1	4.2	0.1	0.4	5.3	0.3	1.0	0.0	0.2	0.5	0.0	4.2	0.9	1.8	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	0.0	3.7	3.5	0.0	0.7	0.1	0.2	0.1	1.0	1.8	1.3	0.0	0.6	1.0	0.0	0.4	0.4	0.1	0.0	2.4	2.3	3.9	9.1	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	14.5	30.9	0.6	0.0	0.0	7.4	0.0	0.0	6.6	0.0	37.7	1.3	1.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.7	0.5	0.0	0.1	1.8	2.8	0.0	0.1	1.0	0.5	5.9	0.0	0.0	1.5	0.0	0.5	0.0	0.1	2.6	0.2	0.0	26.9	5.7	0.1	0.3	0.1	0.1	0.0	0.6	0.1	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767686-6780246	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 155.9;Basal keratinocytes: 167.1;Distal enterocytes: 125.6;Suprabasal keratinocytes: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.6;HeLa: 19.6;hTERT-HME1: 17.8;RT4: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	24400	21000		"Cluster 19: Lung - Lung function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB078457: AB_2532532, HPA058610: AB_2683777"	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	18.6	1.6	1.2	4.0	1.5	1.6	6.0	1.3	1.6	5.2	0.9	15.1	6.6	5.2	0.6	5.5	3.8	16.1	4.0	1.8	1.4	3.9	5.8	18.8	1.9	1.9	2.2	2.8	9.2	3.2	2.3	11.5	2.1	1.9	13.6	1.3	2.1	1.2	2.2	10.6	9.7	2.6	1.5	12.4	20.7	0.5	2.1	0.4	18.9	2.7	1.8	17.2	6.4	2.2	0.1	0.3	0.0	0.0	0.5	0.2	0.0	0.8	3.4	0.0	0.0	31.6	0.1	0.0	0.5	1.1	0.0	10.5	6.2	2.7	0.0	0.0	5.5	0.0	19.6	0.1	1.5	0.0	0.8	0.2	9.2	0.0	17.8	4.0	6.3	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.8	3.7	0.8	6.2	0.1	0.4	2.3	25.0	1.1	1.6	7.3	0.0	0.0	5.5	0.0	6.5	1.5	1.8	2.7	0.0	0.9	0.3	0.9	0.0	3.0	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.5	1.3	1.6	1.8	1.4	1.9	2.2	2.1	1.5	2.1	2.2	9.4	80.1	155.9	0.3	1.1	167.1	45.1	11.0	70.0	0.4	1.4	2.2	4.7	42.9	10.5	1.8	0.0	0.1	3.8	125.6	0.0	23.3	0.3	1.7	34.8	24.1	11.3	0.0	1.1	9.8	0.2	20.2	33.6	3.0	8.8	1.9	41.4	3.4	3.6	0.0	3.5	23.8	0.0	2.9	16.8	0.2	5.9	2.9	8.8	2.8	0.6	6.2	0.0	8.5	1.4	33.5	60.3	0.0	1.3	47.5	28.3	2.1	0.8	0.2	19.7	36.5	48.8	0.0	0.3	43.1	119.3	0.1	2.1	4.3	48.2	43.3
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 6.2;lung: 18.3;pituitary gland: 12.1"	"Cell type enriched"	"Detected in some"	6	"Club cells: 1205.8"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 2.0"	"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	NA	NA		1200000		"Cluster 19: Lung - Lung function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	129.5	0.0	0.0	0.0	0.0	0.0	0.0	1205.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	126.1	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.0	80.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064272-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lung: 48.7"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 189.1;Langerhans cells: 104.3;Macrophages: 153.1"	"Cancer enhanced"	"Detected in all"		"lung cancer: 76.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	NA	NA	55500000	6400000		"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	9.7	0.3	0.0	2.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	2.0	3.9	0.1	0.0	0.9	0.4	0.0	1.6	0.0	0.0	0.2	0.3	48.7	7.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	2.5	0.0	0.0	0.9	9.2	1.5	0.0	4.0	0.2	0.5	0.1	6.1	1.1	0.0	5.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	25.4	0.0	1.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	13.6	0.0	0.0	0.5	4.2	0.0	0.0	0.0	24.5	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.1	0.0	0.4	0.7	189.1	0.0	0.0	0.0	0.0	4.2	104.3	5.3	0.0	153.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.4	0.9	0.0	0.1	0.1	3.4	1.6	2.9	0.0	0.0	0.0
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.2;placenta: 22.8"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;monocytes: 1.4"	"Cell line enriched"	"Detected in single"	14	"THP-1: 3.3"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	34.2	3.9	0.3	8.6	0.6	0.4	4.4	1.3	3.0	4.0	5.7	10.5	14.3	1.4	1.0	4.8	2.5	8.6	4.5	0.3	0.7	2.1	3.3	4.9	18.1	1.0	0.6	1.0	1.0	0.8	0.7	22.8	0.8	0.8	13.9	0.1	2.1	1.9	0.9	1.4	19.3	10.6	0.9	2.4	4.1	2.1	0.6	5.4	1.4	1.5	2.3	20.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.3	0.6	1.3	3.0	0.3	0.7	1.0	0.6	0.8	0.9	0.6	0.8	0.3	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	15.6	14.7	0.3	0.0	12.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.1
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555649-17583162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No		9700	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	38.6	14.3	5.9	38.1	6.9	32.9	27.5	7.9	8.4	31.1	10.6	27.7	16.2	28.4	4.4	17.9	26.5	19.0	22.4	7.1	9.1	12.7	16.3	34.9	29.7	12.1	9.3	23.5	15.8	9.0	10.1	40.9	12.3	15.5	15.2	3.2	15.9	16.3	15.1	23.9	24.7	35.4	7.6	39.5	18.2	11.9	18.9	9.9	14.7	7.5	15.8	28.1	22.8	12.6	103.1	118.0	56.7	79.8	222.3	136.3	90.9	95.9	55.1	121.8	125.9	90.4	159.6	53.0	164.7	166.9	104.2	91.5	58.4	110.6	73.4	29.5	94.9	51.2	147.4	87.9	121.6	123.0	147.8	115.2	97.6	136.7	56.7	49.7	138.8	33.3	105.5	25.8	45.1	45.6	61.9	81.1	43.0	75.8	115.3	65.2	73.8	80.9	26.4	67.2	41.2	29.9	102.8	80.6	97.0	36.7	41.9	177.7	98.7	240.8	67.7	215.3	156.2	45.4	125.1	58.3	142.7	232.4	113.0	1.7	25.7	12.5	5.2	28.1	2.8	3.5	4.8	4.9	18.1	3.3	3.4	5.3	3.6	2.1	20.8	7.0	3.1	14.5	5.9	6.9	7.9	8.4	7.1	9.1	12.1	9.3	12.3	7.6	18.9	12.6	35.0	19.2	23.5	11.1	10.3	19.5	7.0	10.4	10.8	3.7	8.8	9.5	11.2	10.0	15.5	11.0	6.2	7.9	28.6	14.7	0.0	13.1	3.6	8.5	28.5	29.3	5.4	10.3	10.9	8.2	76.2	30.9	20.9	13.6	8.8	20.3	7.9	14.2	91.0	13.5	9.9	15.1	4.1	70.7	24.1	3.1	19.0	59.6	17.8	19.7	26.6	2.3	10.3	6.6	12.8	10.4	7.6	21.8	6.0	9.5	9.5	4.4	8.7	3.6	13.1	9.5	24.3	2.5	13.1	13.8	20.9	8.3	12.0	24.9	18.2	8.4
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073789-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lung: 2.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 11.4;Basal respiratory cells: 11.3;dendritic cells: 17.7;Ductal cells: 18.3;Pancreatic endocrine cells: 24.9;T-cells: 28.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 6.2"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 6.2"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 91.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	23900		"Cluster 15: NK-cells - Transcription"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	9.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	91.3	0.1	5.1	0.0	7.4	0.0	1.5	0.0	5.3	0.2	0.0	6.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	20.8	13.8	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.3	3.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	11.4	0.0	0.3	1.5	0.1	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	17.7	0.1	0.0	18.3	0.0	0.3	0.2	4.8	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.7	1.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.6	0.0	28.6	0.0	0.0	1.1
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877580-102012130	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 94.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 321.8;Early spermatids: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"BJ hTERT+: 532.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (8.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.19e-2)"	"prognostic favorable (6.52e-8)"	"unprognostic (1.15e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.07e-2)"	14.9	15.4	3.5	18.9	3.9	36.9	11.3	5.0	4.2	8.9	7.5	10.2	7.0	10.2	5.3	10.7	9.4	16.8	8.3	3.6	4.5	23.7	7.8	94.1	18.2	4.3	3.4	7.3	8.4	6.1	5.9	20.1	3.7	9.1	9.4	4.3	11.1	7.2	4.7	9.0	9.3	12.6	3.2	11.4	15.7	4.9	4.7	9.3	7.4	5.4	10.5	37.2	7.9	5.5	10.6	20.5	7.4	2.3	93.4	21.4	40.4	77.2	532.4	76.2	118.3	6.9	19.8	1.9	8.5	128.2	29.4	15.5	1.9	32.2	104.8	11.3	6.2	2.6	17.5	27.2	43.1	3.0	5.5	25.5	14.0	26.8	28.7	65.1	41.5	2.4	9.5	3.6	20.0	8.3	1.8	9.0	5.1	26.3	4.9	3.4	5.4	1.9	80.9	49.4	1.4	1.6	42.8	4.8	20.5	20.3	14.9	11.7	25.3	53.3	9.5	9.3	14.2	10.7	5.3	1.4	17.9	26.8	14.2	10.2	9.0	6.0	1.6	10.2	2.0	2.7	1.3	1.8	3.1	1.4	0.9	1.1	8.6	3.3	5.8	0.8	1.9	2.8	3.5	3.9	5.0	4.2	3.6	4.5	4.3	3.4	3.7	3.2	4.7	5.5	17.2	54.5	321.8	4.9	10.7	20.9	21.5	42.4	28.5	1.6	12.8	8.0	4.3	10.0	25.2	29.5	0.0	28.1	5.0	1.3	1.9	11.4	145.0	12.7	30.8	16.5	0.0	11.3	0.5	21.4	30.9	30.5	10.2	15.6	24.1	3.2	10.0	2.0	60.6	0.0	4.7	1.6	14.2	40.5	31.1	80.6	14.0	51.9	8.8	3.7	24.6	3.2	5.2	10.1	0.6	21.7	0.3	10.5	30.9	34.2	0.3	23.4	7.4	0.2	13.1	14.4	9.9	1.2	4.5	3.2	6.1	22.0	6.4	7.3	1.2	22.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360489	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 4.1;lymphoid tissue: 2.5"	"Group enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 16.8;Macrophages: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.5;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.8"	"Not detected"	"Not detected"											HPA044681	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 19: Lung - Lung function"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044681: AB_2679043"	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	4.1	0.1	0.3	2.5	0.5	0.8	2.3	0.3	0.6	0.0	0.5	1.3	0.3	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.4	0.2	0.2	0.4	0.2	1.2	0.5	0.2	0.4	0.1	0.4	0.4	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.4	1.2	0.5	0.1	0.4	0.2	0.6	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.3	0.6	0.5	0.4	1.2	0.5	0.5	0.4	0.4	1.1	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	16.8	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.6	1.8	0.3	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HTR3C		ENSG00000178084	"5-hydroxytryptamine receptor 3C"	Q8WXA8	3	184053047-184060673	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lung: 2.4"	"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 19: Lung - Lung function"		"Cluster 31: Spermatids - Spermatogenesis"							"unprognostic (4.56e-2)"		"unprognostic (2.01e-1)"		"unprognostic (1.39e-1)"		"unprognostic (1.61e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.72e-2)"	"unprognostic (1.75e-1)"		"unprognostic (3.88e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	8	"cerebellum: 7.1"	CAB026215	Approved				"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	19.3	7.5	3.3	20.4	3.7	11.7	18.3	3.0	4.6	21.5	3.6	12.3	16.2	15.0	4.6	11.5	18.8	23.2	17.8	2.8	4.4	14.1	19.5	44.5	21.3	5.7	3.9	3.7	11.5	2.2	4.6	16.1	4.6	10.4	10.9	0.3	8.0	5.3	7.1	11.2	15.7	12.1	4.8	15.1	16.3	3.2	4.6	5.7	12.1	10.2	11.6	25.7	12.7	3.5	16.8	2.4	0.0	0.7	21.5	4.9	4.3	8.6	18.4	10.7	11.4	0.3	70.8	1.9	41.3	16.0	6.0	15.6	2.0	12.1	2.4	78.5	3.5	2.0	4.9	1.2	42.7	0.9	0.6	4.1	4.2	6.0	0.2	4.4	29.1	1.3	20.5	23.5	0.3	9.3	3.6	8.9	0.4	6.7	6.8	10.0	0.0	13.4	2.8	1.3	0.1	0.1	12.9	1.4	0.6	0.2	6.1	8.0	10.8	0.5	1.3	30.1	11.2	20.5	6.2	0.4	4.9	12.4	0.7	10.2	26.0	6.6	18.9	32.8	29.1	10.8	14.7	19.7	7.1	6.4	6.1	11.0	7.5	11.5	21.0	0.1	17.7	12.8	3.3	3.7	3.0	4.6	2.8	4.4	5.7	3.9	4.6	4.8	4.6	3.5	25.2	6.4	5.0	1.3	6.0	5.7	5.7	9.9	4.6	0.0	4.4	3.0	5.8	22.8	3.3	0.0	0.0	0.6	4.2	5.8	0.0	39.1	1.7	5.1	23.0	21.0	5.4	19.8	3.3	55.2	1.6	37.6	9.7	6.7	3.8	0.1	36.0	8.7	6.6	0.0	0.9	6.8	2.0	14.7	5.5	2.1	5.0	7.3	3.6	12.2	55.0	0.0	4.1	1.0	0.3	35.5	13.3	0.7	22.2	20.1	9.3	0.1	3.4	0.0	0.0	7.1	6.4	0.2	0.4	4.6	6.5	0.1	7.8	0.0	9.3	6.8
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122215-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lung: 219.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 486.7;monocytes: 339.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 27.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.6;T-cells: 4.8"	"Group enriched"	"Detected in many"	4	"EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7"									"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		59000	"Cluster 13: T-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.7	0.6	0.2	33.1	0.4	0.8	1.3	0.3	0.2	1.4	0.0	3.2	2.7	0.7	2.6	4.4	1.1	3.9	0.3	0.2	0.1	0.6	0.9	219.7	16.1	0.2	0.1	0.3	7.8	1.9	0.5	1.9	0.1	2.7	6.8	0.6	27.2	2.5	0.2	7.0	3.1	4.3	0.2	9.0	4.1	22.7	0.3	28.1	7.5	0.2	21.5	11.2	0.9	0.0	10.7	0.3	0.2	1.7	0.1	0.1	8.7	0.2	2.8	1.8	0.5	2.8	5.3	0.1	169.5	0.9	18.9	1.5	3.7	6.4	0.2	46.6	5.9	0.0	0.3	0.4	60.4	0.0	1.4	0.9	59.1	0.1	7.4	0.0	7.6	52.7	0.4	9.9	0.2	0.2	2.5	0.4	0.3	0.9	2.7	0.0	0.0	0.8	0.2	3.4	0.7	0.4	0.8	0.3	5.0	2.1	3.4	0.4	8.3	0.0	3.0	0.4	0.2	3.5	13.2	0.5	0.0	0.1	0.1	0.3	0.0	5.6	0.2	0.0	2.4	0.1	1.8	1.1	0.0	0.2	2.3	1.3	1.3	0.6	0.0	0.0	4.8	0.7	0.2	0.4	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	64.1	486.7	0.0	2.0	6.0	2.9	2.4	8.6	0.0	0.3	0.6	1.2	1.5	9.5	1.8	0.0	2.9	0.1	0.1	0.0	0.6	34.3	1.3	0.2	0.5	0.0	0.4	0.7	6.1	0.4	1.0	1.5	0.8	18.9	0.4	0.0	0.0	1.3	0.0	0.6	0.2	0.0	0.0	41.1	84.9	0.6	4.8	1.8	0.0	339.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	4.1	1.6	0.1	0.0	11.5	0.0	0.0	0.4	0.3	14.0	0.5	4.0	5.7	1.2	2.3	0.0	0.5	2.2
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 122.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 19.3;TIME: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		170000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	54.4	28.7	0.8	24.0	1.7	0.7	16.3	0.3	3.5	17.2	9.2	16.1	9.9	7.2	1.7	13.1	11.9	27.7	10.2	1.1	0.7	7.6	40.9	122.3	15.2	1.4	0.9	6.2	8.1	4.6	1.5	54.3	1.1	2.2	18.5	0.1	4.9	8.0	1.8	2.8	17.5	30.3	0.7	50.6	9.7	7.5	2.8	8.0	5.5	8.7	3.0	29.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.3	3.5	1.1	0.7	1.4	0.9	1.1	0.7	2.8	1.3	4.0	32.1	43.5	1.3	3.5	0.4	0.0	0.0	0.0	0.0	128.9	1.7	3.6	11.5	7.4	0.0	0.0	0.9	1.0	1.4	0.0	0.1	27.3	0.0	0.1	39.0	0.0	3.2	0.8	0.4	1.4	2.5	0.0	0.1	13.9	0.1	397.7	13.1	176.1	0.0	1.3	0.9	0.0	361.4	46.8	19.4	1.5	316.5	0.0	60.9	0.5	0.0	0.0	0.5	0.5	0.1	1.5	0.0	1.0	0.0	2.2	0.1	5.8	0.0	32.9	3.0	2.2	0.4	2.3	1.2	0.4	2.1	4.7	1.7	0.8	0.1
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lung: 43.9"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in single"	26	"olfactory bulb: 20.2"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.2	0.4	0.2	0.1	2.2	0.3	0.4	0.3	0.2	0.3	1.0	1.2	0.3	0.4	1.0	0.2	0.3	0.7	0.2	0.1	0.0	43.9	0.5	0.4	0.2	1.8	0.1	0.0	0.0	0.7	0.4	0.3	0.6	0.4	0.1	1.2	0.0	0.0	2.2	1.6	0.1	0.3	0.4	0.6	0.2	3.8	0.3	0.0	1.8	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	3.2	0.2	0.2	0.2	0.3	0.4	0.7	0.2	0.4	0.2	0.4	0.1	0.2	0.3	0.2	96.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 120.1"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 137.3;Kupffer cells: 322.8;Langerhans cells: 86.0;Macrophages: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.9"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 105.2;REH: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					NA	NA		67000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	25.9	18.4	4.2	17.5	5.4	13.0	9.7	5.5	10.6	11.6	13.6	8.5	6.6	8.0	6.3	6.2	5.6	29.8	8.7	3.8	6.5	6.7	24.9	120.1	7.0	15.0	7.5	6.1	11.4	6.3	2.6	27.4	10.8	3.6	10.6	5.9	6.3	6.4	2.3	3.5	9.4	17.9	6.9	16.0	6.2	6.2	16.9	4.4	5.2	1.4	2.9	17.4	1.9	22.9	1.5	2.1	3.0	1.5	1.4	1.3	1.4	0.7	105.2	0.3	0.6	3.7	0.4	3.4	5.1	1.0	0.7	0.7	0.7	1.0	2.0	0.4	4.3	4.6	5.1	4.2	0.9	2.4	2.5	0.7	0.8	0.8	1.5	1.8	0.2	1.9	1.7	2.9	1.9	4.3	1.4	1.4	0.5	1.6	1.3	40.7	2.3	1.0	2.0	5.8	2.8	1.2	1.0	2.8	0.2	5.0	0.4	1.2	2.4	2.8	0.9	10.8	2.8	9.5	8.6	7.4	1.1	1.5	2.2	1.7	3.3	0.6	1.0	16.9	0.4	1.1	0.7	0.7	1.1	1.5	1.3	0.9	3.2	0.4	8.8	0.5	0.7	0.8	4.2	5.4	5.5	10.6	3.8	6.5	15.0	7.5	10.8	6.9	16.9	22.9	2.0	22.4	35.9	0.0	2.7	2.7	0.0	0.0	0.0	1.6	0.5	1.4	2.0	2.8	8.1	3.7	25.0	0.5	0.1	0.0	1.9	0.0	2.9	0.0	0.0	6.3	0.0	2.7	0.3	0.0	1.0	2.1	0.0	0.0	17.7	0.1	4.6	1.7	137.3	0.0	3.0	0.1	0.0	322.8	86.0	3.6	1.8	172.5	0.0	28.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.4	6.6	0.7	19.7	1.0	0.7	4.2	1.3	0.1	2.0	0.8	2.6	0.2	0.0	0.3
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 1075.5"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 3072.3"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 4.3;dendritic cells: 8.7"	"Cell line enriched"	"Detected in some"	31	"U-698: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		1500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.4	0.9	0.8	1.6	0.9	0.1	0.5	0.9	0.9	0.7	0.7	0.6	0.4	0.5	2.0	0.4	1.0	0.1	0.4	0.8	0.9	106.3	1.2	1075.5	1.2	0.9	0.8	2.1	1.0	0.2	0.6	0.4	0.9	1.0	0.4	0.4	0.6	1.0	0.2	1.1	1.5	0.1	0.8	1.1	0.9	1.8	1.0	0.4	1.7	0.0	0.5	0.4	0.7	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.4	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.7	0.2	0.5	0.2	0.3	0.4	0.6	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	1.0	0.0	0.2	0.4	42.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	4.3	0.2	0.3	2.6	1.7	0.4	0.4	0.5	0.4	0.7	8.7	0.0	1.1	0.8	0.9	0.9	0.9	0.8	0.9	0.9	0.8	0.9	0.8	1.0	1.1	0.3	522.4	3072.3	0.3	3.8	0.1	0.5	0.2	0.0	1.3	0.8	0.9	0.4	1.5	45.9	46.0	4.2	0.5	0.4	0.8	9.8	0.6	47.2	12.6	0.4	6.2	0.0	0.4	0.5	0.8	0.3	5.8	0.5	1.5	69.4	1.0	0.4	0.4	0.3	0.0	0.5	1.0	0.0	1.6	5.3	9.1	0.9	7.9	0.0	1.9	0.2	1.5	1.0	0.0	1.4	0.1	2.3	0.4	0.6	0.4	2.0	276.1	16.4	0.9	0.0	0.3	0.3	1.4	1.4	0.0	0.6	0.1	12.9	0.4	0.9	0.1
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Disease related genes, Predicted secreted proteins"	Neurogenesis		"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 106.5;placenta: 60.1;retina: 57.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Bipolar cells: 69.8;Early spermatids: 217.1;Late spermatids: 221.7"	"Cancer enriched"	"Detected in many"	4	"lung cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.5;U-266/70: 20.8;U-266/84: 85.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 11.1;olfactory bulb: 34.0"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	4.8	2.6	1.1	0.9	1.7	0.0	3.2	4.7	1.2	14.2	9.3	6.5	2.9	6.0	4.3	7.7	20.4	9.4	5.2	1.8	2.6	27.1	0.4	106.5	0.3	8.8	12.9	42.5	0.5	0.7	5.3	60.1	15.2	16.7	8.3	57.4	2.2	4.4	4.3	1.7	4.7	3.5	7.6	0.3	4.1	10.4	3.7	2.4	1.3	14.0	0.2	9.0	1.9	5.4	0.2	0.0	10.6	0.0	13.9	11.3	0.2	0.2	0.5	0.2	0.5	1.6	0.0	0.0	0.0	48.5	0.8	0.0	0.0	0.0	1.1	0.9	1.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	14.3	1.0	0.0	0.2	0.1	0.9	7.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.6	0.2	0.0	0.0	11.5	0.0	0.2	0.5	20.8	85.8	0.0	3.9	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	4.7	1.2	1.8	2.6	8.8	12.9	15.2	7.6	3.7	5.4	10.9	246.8	48.3	1.6	0.0	1.1	0.0	0.0	0.0	69.8	0.2	0.1	1.6	8.6	28.6	12.9	18.8	0.3	0.0	5.3	0.0	0.0	217.1	0.9	4.7	11.7	1.8	0.0	0.0	0.2	0.0	14.9	0.0	0.1	2.5	0.1	2.9	0.0	0.1	1.7	8.0	0.8	0.0	0.0	0.8	221.7	3.4	0.4	5.4	6.5	0.0	12.2	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.0	12.5	20.0	0.0	1.2	3.6	6.4	5.0	0.3	0.9	0.5	0.3	13.0	1.2	0.1
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Microglial cells: 26.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074367			Approved	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	10.6	2.9	3.0	8.8	3.2	6.8	9.5	2.5	2.6	5.3	4.6	5.3	2.2	6.1	2.6	4.7	6.5	5.4	7.3	2.4	3.2	3.9	2.2	11.9	6.1	7.6	4.9	10.3	1.8	2.7	2.9	12.2	4.7	4.0	4.3	0.6	6.2	3.2	4.0	5.9	5.4	7.3	3.6	11.1	4.8	1.9	5.6	3.5	10.8	4.0	5.0	7.3	5.0	2.8	4.8	2.5	3.5	10.5	2.2	10.3	5.3	3.3	2.3	5.5	7.0	2.2	5.7	6.9	3.8	4.2	6.1	11.2	3.5	5.8	3.7	3.6	3.0	9.7	7.7	2.2	2.8	4.3	7.0	9.6	2.5	3.5	3.0	4.9	18.3	10.1	5.2	2.4	5.0	2.8	6.2	7.7	4.1	5.3	4.5	7.4	4.0	6.3	1.8	3.8	0.6	12.4	4.2	10.7	3.7	4.8	3.6	9.6	7.7	4.8	7.6	6.0	4.5	2.2	8.0	0.3	3.5	15.1	5.1	13.7	3.7	13.5	8.1	5.0	8.9	7.5	5.5	5.3	3.3	10.9	4.9	4.0	2.8	8.5	6.6	8.0	4.8	2.6	3.0	3.2	2.5	2.6	2.4	3.2	7.6	4.9	4.7	3.6	5.6	2.8	19.3	3.2	15.1	7.2	6.6	0.8	0.5	1.0	5.2	2.4	2.9	2.9	4.9	1.5	5.0	5.5	0.0	5.0	6.7	4.5	0.0	1.3	0.2	4.4	1.7	12.0	0.0	3.4	5.3	2.1	2.3	8.2	1.1	4.6	2.5	7.8	13.6	1.3	4.6	0.0	1.4	5.5	2.0	3.1	3.7	0.0	0.6	4.3	5.4	26.2	4.0	0.6	6.2	2.5	1.1	1.7	1.7	1.9	3.1	0.2	1.6	0.5	2.9	0.2	0.0	2.5	5.6	0.0	0.6	5.4	1.8	1.5	5.3	1.0	5.6	0.8
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278542	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 24.6;placenta: 31.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"eosinophil: 230.1;plasmacytoid DC: 98.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 98.0;granulocytes: 230.1"	"Cell line enriched"	"Detected in single"	68	"HMC-1: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	7.9	0.8	2.6	10.8	3.8	0.7	7.0	3.4	7.1	5.9	24.6	11.7	6.9	8.0	0.6	20.2	1.1	5.2	5.3	3.2	1.8	2.0	1.0	7.2	9.6	1.3	2.2	1.5	0.6	2.4	0.9	31.7	1.1	0.7	9.7	0.4	1.2	1.3	2.5	1.9	12.0	4.1	1.0	5.7	11.2	0.5	3.8	4.8	2.5	6.4	6.7	9.2	1.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	10.3	0.4	230.1	1.1	0.3	19.0	3.7	0.6	2.2	13.8	17.0	0.1	0.0	8.9	11.7	0.1	98.0	1.1	2.0	2.6	3.8	3.4	7.1	3.2	1.8	1.3	2.2	1.1	1.0	3.8	3.3	5.8	3.2	0.5	31.0	13.9	2.3	0.0	0.0	0.0	2.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.1	54.4	0.0	0.0	0.0	0.4	1.0	35.5	5.9	0.0	0.4	41.2	0.0	0.2	3.9	0.0	0.7	45.7	0.0	0.0	0.0	0.6	0.0	16.4	0.0	0.0	0.8	61.3	0.5	0.0	22.7	3.6	5.6	1.2	0.4	1.0	29.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.7	0.4	26.3	1.6	29.3	0.0	0.1	0.2	1.7	0.3	4.8	1.5	0.1	0.1
RTKN2	"bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1"	ENSG00000182010	"Rhotekin 2"	Q8IZC4	10	62183035-62268844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 77.5"	"Group enriched"	"Detected in many"	10	"Alveolar cells type 1: 1753.2;Early spermatids: 480.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.6"	"Immune cell enriched"	"Detected in some"	8	"T-reg: 16.7"	"Lineage enriched"	"Detected in single"	72	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"A-431: 45.2;HaCaT: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037946, HPA038446"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Mitochondria	"HPA037946: AB_10795398, HPA038446: AB_10796218"	"unprognostic (2.33e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-3)"	"unprognostic (6.66e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.48e-4)"	"unprognostic (3.70e-11)"	"unprognostic (3.95e-2)"	"unprognostic (9.34e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.55e-1)"	0.2	0.1	0.1	1.7	0.4	0.8	1.1	0.6	1.6	1.5	0.0	1.6	1.3	0.9	0.1	7.1	0.2	0.7	0.1	0.2	0.0	0.4	0.2	77.5	3.5	0.0	0.0	0.2	0.1	0.4	0.8	1.3	0.0	1.1	2.0	0.9	1.4	0.2	0.0	1.2	1.5	0.4	0.0	1.4	1.2	7.6	0.1	3.9	0.6	0.0	3.4	1.2	3.1	0.5	45.2	2.6	23.2	10.8	0.0	0.1	5.6	6.4	7.4	7.2	11.2	18.7	8.9	0.1	2.8	2.6	7.3	35.3	13.1	1.0	7.4	6.4	8.9	7.5	5.4	7.8	0.1	9.9	5.6	0.3	0.6	8.8	0.9	3.8	1.1	11.8	0.5	0.2	9.7	5.6	19.8	13.1	9.8	6.7	8.7	16.9	24.9	0.1	4.6	19.5	12.6	14.5	4.3	14.8	6.0	6.8	13.4	5.6	0.1	3.3	20.8	0.2	16.5	0.1	0.1	17.2	4.2	0.0	5.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.4	0.1	0.1	0.6	0.3	0.2	0.1	0.0	0.1	16.7	0.2	0.1	0.4	0.6	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1753.2	45.8	0.3	1.5	4.7	10.2	3.0	0.0	0.7	5.0	3.6	0.5	1.5	10.9	0.0	0.0	9.0	2.0	1.9	0.0	1.6	480.3	5.6	1.4	0.7	1.8	1.7	21.5	1.6	7.2	2.9	7.1	10.8	3.8	12.9	1.1	0.0	2.4	0.0	2.5	8.5	6.1	0.6	2.9	102.8	2.1	2.1	1.8	1.0	0.4	0.3	0.0	0.5	1.0	15.4	0.7	1.9	3.3	9.7	0.5	1.9	2.8	0.5	0.0	0.6	3.4	23.5	24.6	26.2	1.8	2.1	17.4	2.9	7.0	97.3
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lung: 3079.0"	"Cell type enriched"	"Detected in some"	4	"Club cells: 43564.7"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	71	"HaCaT: 1977.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	NA	NA		13000000		"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	1.1	2.0	0.6	0.9	0.7	0.1	0.3	1.3	1.1	0.6	0.3	0.2	0.4	0.2	0.7	11.0	334.2	0.2	0.6	0.5	0.6	0.2	0.4	3079.0	0.2	0.6	0.9	2.0	1.9	0.0	2.4	1.7	0.5	85.1	0.0	0.2	0.5	0.9	0.3	0.3	1.6	0.0	0.5	7.2	4.3	0.2	1.0	2.8	0.4	0.0	5.9	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	1977.1	0.0	0.3	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.0	0.6	1.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.0	1.0	2.0	0.0	1.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.3	1.1	0.5	0.6	0.6	0.9	0.5	0.5	1.0	0.5	0.0	1125.0	2573.3	0.0	0.0	0.0	71.4	3938.5	0.0	0.0	0.0	0.0	0.0	0.0	43564.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	113.5	0.0	0.0	0.1	0.0	0.0	304.5	0.0	0.5	691.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4534.8	0.0	0.0	0.7	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	134.7	0.0	0.0	9997.0	0.0	0.0	0.0	850.3	0.0	0.0	3.9	0.0	0.0	83.7	0.0	0.0	800.2
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	124	"lung: 1271.2"	"Group enriched"	"Detected in some"	8	"Alveolar cells type 2: 4396.4;Club cells: 6565.6"	"Cancer enriched"	"Detected in some"	10	"lung cancer: 211.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	50	"basophil: 71.6"	"Lineage enriched"	"Detected in many"	50	"granulocytes: 71.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.1;EFO-21: 52.3;NTERA-2: 61.0;PC-3: 302.9;SuSa: 120.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		800000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (3.85e-1)"	"unprognostic (1.77e-1)"			"unprognostic (2.99e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.84e-2)"		"unprognostic (3.17e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.90e-8)"	"unprognostic (9.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.11e-2)"	0.6	0.6	3.3	1.5	2.4	2.4	4.0	5.3	6.0	0.7	0.6	0.6	1.0	1.7	5.0	2.1	1.4	1.2	1.7	3.3	6.2	1.2	1.3	1271.2	2.8	3.4	1.2	2.1	0.6	0.7	1.1	2.0	3.1	1.1	1.8	10.2	6.2	1.4	2.1	5.0	1.4	0.9	0.3	4.2	4.1	1.9	2.0	1.3	7.2	0.8	2.2	0.7	0.1	2.6	89.1	1.3	1.1	2.0	1.1	0.6	2.3	1.4	0.3	0.2	0.2	0.5	1.1	0.4	52.3	0.3	0.8	0.8	2.5	1.3	0.5	0.3	1.6	3.4	10.5	0.3	0.0	0.7	3.3	1.4	0.8	0.7	0.0	2.0	0.2	0.3	2.4	1.1	0.2	1.7	0.9	0.8	61.0	0.0	302.9	0.2	0.9	0.3	1.2	0.7	4.3	1.1	12.3	1.1	0.2	120.6	1.3	0.6	1.7	1.2	35.5	1.6	1.3	1.7	1.4	0.4	0.4	1.5	4.1	71.6	1.0	0.2	0.4	0.7	0.1	0.2	0.2	0.2	0.6	0.4	0.0	0.2	0.4	1.4	0.9	0.3	0.2	0.1	3.3	2.4	5.3	6.0	3.3	6.2	3.4	1.2	3.1	0.3	2.0	2.6	0.0	618.6	4396.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6565.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	14.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.2	106.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	623.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.2
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 49.1;lung: 179.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 535.2;Alveolar cells type 2: 806.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"CACO-2: 12.0;CAPAN-2: 5.5"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.2	0.2	0.5	0.1	0.6	0.0	0.3	0.5	0.9	4.7	0.5	0.1	0.0	0.4	0.0	49.1	0.6	0.8	0.2	0.5	0.5	6.1	0.4	179.1	0.2	0.6	0.6	0.4	4.4	0.3	0.1	0.2	0.6	0.2	0.0	0.1	4.1	0.1	0.6	0.1	0.2	0.1	0.6	0.3	7.9	1.7	0.5	0.1	2.0	0.1	0.2	0.2	21.6	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.9	0.5	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.2	535.2	806.4	0.0	1.0	0.1	0.1	0.0	0.0	0.5	0.9	0.3	0.0	140.2	111.8	53.3	0.0	0.1	0.0	0.0	3.9	22.7	3.8	76.1	2.5	2.1	0.0	0.0	0.0	35.6	0.0	0.8	13.7	23.0	12.6	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	13.7	0.3	1.3	0.0	0.0	0.1	2.8	0.0	0.0	0.1	94.2	0.0	0.4	0.5	0.3	0.0	0.8	8.1	0.1	0.0	1.1	0.4	7.5	1.7	2.8	0.0	0.0	1.7	0.1	0.1	1.1
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1048	"lung: 7084.8"	"Cell type enriched"	"Detected in some"	11	"Alveolar cells type 2: 13480.7"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	27	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 43.2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.5	6.7	0.1	2.6	0.1	0.0	0.5	0.3	0.3	0.9	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	0.8	0.2	0.0	0.2	0.9	7084.8	0.0	0.0	0.0	6.3	0.7	0.0	0.3	1.4	0.0	1.0	0.0	0.0	0.2	4.8	0.8	0.8	0.4	0.0	0.0	4.9	3.8	0.3	0.0	1.5	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.1	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1160.3	13480.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560407	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	404	"lung: 10798.8"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 2: 16905.3"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BEWO: 7.3;NB-4: 8.3;RPMI-8226: 26.1;U-2197: 14.7"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.7	12.1	0.4	4.6	0.6	0.0	1.0	3.1	0.9	1.4	0.0	1.4	0.0	0.2	0.1	0.4	0.2	0.0	1.1	0.5	0.4	0.4	1.1	10798.8	0.0	1.2	0.0	6.5	1.3	0.0	0.4	2.3	1.3	26.7	2.6	0.2	0.4	8.3	1.0	1.1	0.5	0.1	0.0	6.7	10.5	0.5	0.3	2.7	0.8	0.0	0.1	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.4	0.0	0.0	0.2	0.0	26.1	0.0	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	14.7	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.6	3.1	0.9	0.5	0.4	1.2	0.0	1.3	0.0	0.3	0.6	0.0	1593.0	16905.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	22.3	1.8	0.0	0.3	3.1	0.0	22.0	0.0	0.2	431.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.2	2.0	0.0	0.0	1.0	0.0	0.1	135.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.7	0.0	2.4	0.1
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"lung: 3566.0"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 15343.4"	"Cancer enriched"	"Detected in many"	5	"lung cancer: 1306.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.5;U-2197: 6.7;U-266/70: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		80000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.8	4.4	1.5	2.2	1.4	0.4	0.5	1.7	3.0	0.5	1.1	0.5	0.3	0.2	0.7	0.4	0.3	0.2	1.4	1.3	2.1	2.1	1.2	3566.0	0.3	1.4	1.1	11.0	0.9	0.2	5.4	1.5	1.5	1.2	0.4	2.9	0.5	2.0	1.2	0.8	0.7	0.1	0.8	4.1	5.1	0.4	1.4	0.3	113.1	0.3	0.2	0.2	0.4	1.5	0.1	0.2	0.2	0.5	0.3	0.5	2.8	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.1	0.1	1.4	0.0	0.3	0.2	0.1	0.5	0.0	0.4	0.3	0.4	0.1	0.3	1.1	3.5	1.6	0.5	0.4	1.3	0.2	0.3	0.2	0.3	0.4	0.3	0.0	0.4	0.2	0.3	0.3	0.3	0.0	0.2	0.6	6.7	0.1	2.4	0.6	0.2	0.6	0.5	0.1	0.3	0.6	0.2	0.2	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	0.2	0.7	0.2	0.4	0.4	1.5	1.4	1.7	3.0	1.3	2.1	1.4	1.1	1.5	0.8	1.4	1.5	0.0	3650.6	15343.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1930.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	14.4	0.0	0.0	0.2	0.2	0.0	26.9	0.0	0.0	262.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	0.3	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	185.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	36.5	0.0	0.0	0.2
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	795	"lung: 18462.2"	"Cell type enriched"	"Detected in some"	12	"Alveolar cells type 2: 107013.9"	"Cancer enriched"	"Detected in some"	218	"lung cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;NB-4: 12.4;SCLC-21H: 5.1;U-2197: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010928	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA010928: AB_1857425"		"unprognostic (1.84e-1)"			"unprognostic (1.96e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.13e-1)"	"unprognostic (2.97e-1)"		"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.32e-2)"		2.6	23.2	10.3	10.3	12.1	0.0	0.9	10.8	15.8	1.6	8.3	1.3	0.0	0.4	0.3	0.9	0.4	0.0	2.8	10.2	10.6	1.0	2.8	18462.2	0.0	11.9	11.2	21.5	1.7	0.0	1.1	4.7	10.8	3.0	0.0	0.0	0.8	8.9	2.0	3.1	2.3	0.0	10.3	14.0	6.4	2.8	11.4	0.0	4.3	0.1	0.2	0.1	0.9	15.3	0.0	0.1	0.0	0.0	0.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	5.1	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.1	24.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.1	10.8	15.8	10.2	10.6	11.9	11.2	10.8	10.3	11.4	15.3	0.0	8535.2	107013.9	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1416.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	67.8	0.0	0.0	0.9	0.0	0.0	174.6	0.0	0.0	986.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	30.4	0.0	106.6	23.2	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	339.6	0.0	6.6	0.0	0.3	0.1	0.1	0.0	0.6	0.0	163.4	0.4	0.0	0.1
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937467-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"lung: 507.9"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 2: 1863.1"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 10.0;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	18	"monocytes: 36.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	NA	NA		8200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	1.1	1.8	2.2	0.4	2.4	19.7	0.9	1.7	2.5	1.3	2.3	1.0	0.1	0.5	1.3	1.8	1.8	0.9	1.1	2.2	2.4	1.6	1.0	507.9	0.0	1.7	2.0	1.1	4.2	2.0	3.4	0.7	1.8	1.4	0.1	0.3	1.0	1.2	0.2	5.0	0.4	0.4	1.4	0.6	1.1	1.3	2.6	0.5	5.8	0.2	0.2	0.3	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	10.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.9	2.2	2.4	1.7	2.5	2.2	2.4	1.7	2.0	1.8	1.4	2.6	1.7	0.3	439.1	1863.1	1.0	0.2	0.9	1.3	7.8	1.2	1.7	1.4	1.8	0.7	0.0	38.0	5.5	0.0	0.1	0.0	0.0	1.9	1.4	7.4	0.6	0.1	1.5	0.0	0.0	4.9	5.8	3.0	4.4	0.0	0.9	20.2	1.6	0.4	0.7	0.1	0.0	3.5	0.0	0.0	0.0	2.7	12.2	1.2	2.9	0.0	1.9	0.6	2.8	0.0	0.0	0.6	2.0	0.1	0.4	0.0	0.8	0.0	0.2	9.6	0.5	0.0	1.8	0.4	0.4	0.3	0.6	1.8	0.1	4.3	0.1	0.1	0.6
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3712600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hofbauer cells: 78.6;Kupffer cells: 93.4;Macrophages: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enriched"	"Detected in single"	19	"THP-1: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053457	Supported				"Intracellular and membrane"	NA	NA		260000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA053457: AB_2682158"	"unprognostic (2.05e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.83e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	23.0	13.7	2.0	7.7	2.9	12.3	8.6	1.9	6.5	1.8	7.5	10.2	5.1	2.0	1.8	2.2	7.0	8.5	6.4	1.8	2.2	3.9	8.4	16.7	12.7	10.2	3.3	2.7	1.6	0.5	2.3	18.8	10.9	1.9	6.6	0.3	5.4	1.2	3.7	3.0	11.2	7.7	5.0	18.9	5.1	2.5	10.9	3.6	3.7	2.6	1.9	7.6	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.0	2.9	1.9	6.5	1.8	2.2	10.2	3.3	10.9	5.0	10.9	3.9	0.5	3.2	4.4	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.3	2.4	0.0	0.6	0.0	2.1	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.3	0.0	0.0	93.4	6.3	0.1	0.0	42.6	0.0	3.7	2.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	1.4	1.0	0.0	0.1	0.6	0.6	1.9	0.4	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 99.8"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000		"Cluster 19: Lung - Lung function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	12.1	9.6	4.9	1.9	2.8	0.2	9.5	1.7	5.8	13.6	2.2	4.8	12.8	9.8	0.5	2.8	15.0	1.8	12.5	1.6	5.3	32.6	2.9	99.8	2.2	22.9	6.9	5.4	4.3	1.5	7.1	3.6	26.5	5.6	1.0	0.1	4.7	5.6	2.2	28.2	34.6	3.4	6.8	3.6	6.3	3.2	13.2	0.8	17.8	1.4	1.3	5.4	11.0	10.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.8	1.7	5.8	1.6	5.3	22.9	6.9	26.5	6.8	13.2	10.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
TBC1D9	"GRAMD9, KIAA0882, MDR1"	ENSG00000109436	"TBC1 domain family member 9"	Q6ZT07	4	140620782-140756385	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 91.6"	"Cancer enriched"	"Detected in all"	7	"breast cancer: 85.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.9"	"Group enriched"	"Detected in many"	37	"B-cells: 5.9;dendritic cells: 3.2;monocytes: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000262, HPA006503"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"HPA000262: AB_2665956, HPA006503: AB_2667604"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.61e-6)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.16e-2)"	18.2	9.2	7.2	15.2	7.9	2.0	48.7	22.5	9.4	12.9	35.2	7.3	8.2	8.3	7.8	9.1	10.0	13.8	8.5	8.4	15.3	15.7	12.6	16.3	15.1	7.9	9.6	15.9	9.1	9.8	6.3	20.5	15.4	14.6	6.6	21.0	8.8	21.3	2.2	3.2	12.8	7.7	6.4	33.7	16.8	3.3	12.9	5.6	5.8	6.9	19.4	15.8	7.1	3.3	0.9	11.9	10.9	9.4	26.0	24.3	22.3	15.3	16.3	10.8	13.7	2.4	10.4	0.1	9.5	19.9	13.4	2.4	13.7	10.8	10.1	0.0	7.7	7.0	8.5	10.4	9.4	0.9	1.1	20.1	17.7	9.4	37.2	31.2	30.3	3.7	0.0	0.0	10.2	12.0	1.6	0.1	1.7	12.7	10.4	7.7	17.9	18.1	12.3	22.0	16.0	11.4	15.8	27.4	10.5	18.4	6.4	0.4	47.7	28.3	8.5	18.6	13.3	0.0	0.0	0.1	17.2	1.3	15.7	0.0	1.7	0.0	0.0	1.3	0.0	5.9	0.0	0.0	2.9	2.9	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.7	7.2	7.9	22.5	9.4	8.4	15.3	7.9	9.6	15.4	6.4	12.9	3.3	49.4	54.5	9.3	4.6	42.1	4.6	10.6	21.4	4.0	35.4	91.6	39.4	8.1	17.2	15.1	55.2	4.2	14.1	14.0	8.3	7.9	13.6	0.5	49.4	20.9	32.6	7.7	0.4	54.8	17.2	4.7	15.1	8.2	61.4	0.0	8.0	17.2	23.9	18.3	10.1	66.2	6.6	24.4	39.3	30.3	1.3	13.1	44.8	8.8	78.7	39.5	43.5	1.0	27.6	2.6	12.2	5.8	26.7	25.0	16.3	6.1	5.7	15.9	7.6	0.0	2.8	11.1	0.8	1.7	10.4	3.8	43.2	3.7	16.0	3.1	16.0
TBX4		ENSG00000121075	"T-box transcription factor 4"	P57082	17	61452404-61485110	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 32.3;placenta: 21.0;prostate: 9.0"	"Group enriched"	"Detected in some"	8	"Early spermatids: 6.2;Late spermatids: 14.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;Hep G2: 1.2;OE19: 1.2;THP-1: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB032413, HPA044457"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	32.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	21.0	0.1	9.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	2.9	0.3	0.2	0.2	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	1.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.1	0.0	5.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889113-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	8.9	10.7	0.1	11.0	0.0	0.0	0.3	0.4	1.7	3.3	2.7	24.6	23.4	9.4	13.1	19.4	3.5	20.2	22.6	1.6	0.0	38.3	5.1	58.5	0.3	0.2	0.0	88.3	10.4	1.3	3.5	137.2	0.1	37.0	21.2	0.0	0.1	42.2	1.1	0.1	26.7	14.3	0.0	100.4	21.0	3.4	0.1	0.1	0.3	0.7	0.0	40.3	8.5	0.1	0.0	1.3	0.0	0.2	0.2	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	51.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.7	1.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	5.5	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.0	1.9	123.8	0.5	0.0	0.0	0.5	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	102.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.9	0.1	0.3	0.0	0.0	0.0	0.0	118.3	0.3	20.8	0.3	0.4	1.4	0.0	5.7	0.1	14.5	0.0	0.4
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
TMEM100	"FLJ10970, FLJ37856"	ENSG00000166292	"Transmembrane protein 100"	Q9NV29	17	55719627-55732121	"Predicted membrane proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 192.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 57.8;Endothelial cells: 25.5;Fibroblasts: 40.7;Leydig cells: 40.7;Peritubular cells: 52.6;Sertoli cells: 32.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 28.9;ASC TERT1: 19.5;HHSteC: 44.8;HSkMC: 20.6;U-87 MG: 13.9;WM-115: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055936	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055936: AB_2682975"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.07e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	40.8	5.0	5.4	3.2	5.5	0.0	27.6	4.3	9.0	15.8	6.0	14.5	6.7	3.6	36.6	6.5	8.0	7.3	18.7	5.1	7.0	1.9	7.0	192.5	1.2	5.5	7.0	26.5	2.3	0.8	11.2	54.1	6.0	10.3	11.6	0.4	8.0	24.7	9.7	4.6	13.2	5.5	4.6	6.9	30.2	2.7	8.1	1.1	7.5	14.1	0.6	11.1	8.2	4.7	0.0	0.0	5.9	0.0	28.9	19.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	44.8	0.0	0.0	20.6	0.0	1.4	0.1	0.2	0.0	0.3	1.0	0.1	0.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	1.9	3.9	0.0	0.8	0.0	0.1	13.9	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.5	4.3	9.0	5.1	7.0	5.5	7.0	6.0	4.6	8.1	4.7	57.8	0.0	3.6	2.3	0.1	2.5	0.3	0.0	1.2	0.7	0.4	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	4.0	25.5	0.0	0.0	0.1	0.0	0.0	40.7	1.5	0.2	1.3	0.1	7.1	15.2	0.1	0.0	1.6	0.0	0.0	0.0	4.9	0.5	40.7	0.2	7.2	1.9	0.0	0.0	0.0	17.1	0.0	0.1	0.0	52.6	0.0	0.1	0.0	3.4	0.0	0.1	32.9	10.3	15.1	0.1	0.2	0.7	2.6	0.1	0.5	0.3	0.0	0.3
TRGV9	"TCRGV9, V2"	ENSG00000211695	"T cell receptor gamma variable 9"	Q99603	7	38317017-38318861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.9;prostate: 5.5"	"Group enriched"	"Detected in some"	4	"dendritic cells: 14.6;NK-cells: 22.6;T-cells: 37.7"	"Cancer enriched"	"Detected in single"	126	"prostate cancer: 13.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	13	"gdT-cell: 426.5"	"Lineage enriched"	"Detected in many"	13	"T-cells: 426.5"	"Group enriched"	"Detected in some"	6	"MCF7: 7.7;NB-4: 2.4;U-937: 8.6"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.07e-1)"	"unprognostic (1.18e-1)"			"unprognostic (1.30e-1)"	"unprognostic (3.98e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.41e-1)"	"unprognostic (6.60e-4)"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-1)"	0.4	0.0	0.4	0.5	0.7	1.1	0.1	0.4	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.5	0.0	0.2	0.4	0.5	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.7	5.5	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.4	1.6	0.3	0.1	0.5	1.5	0.0	0.0	0.4	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.3	0.1	426.5	0.6	29.0	0.1	1.6	19.7	0.4	0.0	0.7	8.4	1.4	33.2	0.1	0.5	0.1	38.8	0.4	0.7	0.4	0.5	0.5	0.5	0.7	0.5	0.7	0.4	0.5	0.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.0	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4"	"Cancer enriched"	"Detected in all"	5	"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	31	"dendritic cells: 17.8;monocytes: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		59000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	137.1	68.8	17.9	44.2	18.8	7.8	44.2	17.0	36.6	14.1	21.5	40.9	22.5	15.5	5.3	15.4	66.8	39.6	30.0	18.2	18.3	17.9	51.0	166.0	27.8	25.1	23.6	12.9	14.3	6.8	7.0	139.6	25.8	10.6	31.7	2.2	24.5	9.3	8.2	10.8	43.9	108.3	18.9	69.3	22.9	7.3	37.6	5.4	12.3	12.5	1.8	61.5	11.6	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	18.7	0.1	0.0	11.1	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.5	0.0	0.4	0.1	0.0	5.6	17.9	18.8	17.0	36.6	18.2	18.3	25.1	23.6	25.8	18.9	37.6	26.7	1.3	3.2	16.1	0.0	1.2	2.3	0.3	0.0	0.0	0.0	2.6	0.5	1.8	7.2	3.1	0.0	0.0	5.3	0.3	0.0	0.0	0.1	7.9	0.0	0.0	10.4	0.0	0.0	0.0	0.0	4.9	2.7	0.0	0.0	3.8	0.0	5.0	3.2	989.8	0.0	0.0	0.0	0.0	590.9	111.8	16.6	1.5	328.4	3.6	12.2	1.5	0.5	0.0	0.5	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	4.4	0.0	6.6	0.6	2.0	0.3	0.9	0.5	1.7	12.3	1.5	0.0	0.0	0.2
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	41.9	22.1	14.1	45.9	35.7	48.7	35.7	22.9	26.9	47.0	5.2	40.7	28.6	49.4	24.6	27.7	45.9	39.6	32.5	14.1	35.9	29.0	15.6	58.3	34.5	38.7	22.7	47.7	29.6	19.0	23.8	75.0	40.6	27.6	30.9	76.0	27.4	32.1	23.0	23.2	33.7	44.8	17.0	69.9	32.7	21.6	33.2	24.8	28.8	16.1	35.2	32.8	39.1	80.0	30.8	21.3	65.3	37.5	40.3	49.7	69.7	26.6	37.9	20.6	39.6	32.0	12.2	30.6	29.6	36.6	26.2	28.4	40.0	19.6	30.9	85.3	33.1	48.7	41.9	32.7	75.7	34.1	69.2	60.2	26.3	30.1	18.4	31.5	83.1	31.7	49.8	28.6	36.9	19.4	44.4	38.4	19.4	17.1	17.3	35.5	35.9	18.5	31.1	24.6	20.9	28.8	27.8	27.3	36.7	77.8	22.1	44.5	46.5	25.3	19.2	34.8	26.4	12.8	34.9	31.2	23.9	26.8	23.4	75.0	41.1	71.5	21.6	70.3	26.1	22.1	18.1	24.2	65.5	25.3	17.0	19.7	37.1	21.4	82.5	21.5	30.2	26.4	14.1	35.7	22.9	26.9	14.1	35.9	38.7	22.7	40.6	17.0	33.2	80.0	300.4	221.2	476.1	189.7	245.4	249.2	185.6	138.4	253.8	91.9	186.7	147.7	67.5	144.4	194.2	239.1	348.2	360.7	183.2	222.7	27.4	124.9	153.0	201.2	187.6	254.9	194.4	148.1	229.5	65.1	217.2	284.6	190.6	301.5	163.5	436.3	316.6	43.3	228.2	82.4	267.8	191.5	162.8	412.6	288.9	26.6	141.4	358.9	197.5	206.1	153.2	170.5	112.3	349.3	658.2	76.7	185.4	122.6	144.9	196.3	178.7	30.7	137.5	381.4	124.9	243.8	221.9	119.6	104.8	202.2	280.3	714.5	183.9	98.5	133.6	148.9